clinical phase Videos
-
GenBio - Genome Biologics: Our Technology - Vdeo
Modern drug discovery is inefficient, expensive and risky. On average, there are 2000 failed compounds sitting on pharmaceutical companies shelves, and this number grows at the rate 200 drugs per year. Furthermore, the average costs of a successful drug introduction is a staggering $3bln with an average time-to-market of more than 10 years. This is due to extensive discovery costs including: R&D, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you